Therapy for vasogenic brain oedema (VEE) is still an unsolved problem.
Experimental work with the aim of establishing an oncotherapeutic opt
ion is presented. VBE is performed by focal freeze injury in rats. Usi
ng a stereotactic head holder hypo- or hyperosmolar human serum albumi
n is administered via the intraventricular route. The goal is to enhan
ce the migration of oedema fluid with the aid of onco:ic pressures. Ea
rly and late results are obtained for each group respectively four and
twenty-four hours after the infliction of cold injury. The efficacy o
f therapy is evaluated by cerebrospinal fluid (CSF) osmolality, cerebr
al water content, tissue specific gravity, and blood-brain barrier (BB
B) permeability. Posttherapeutic values for CSF osmolality are obtaine
d by cisterna magna puncture. Hyperosmolar CSF after performance of co
ld injury (p < 0.05) is thought to be a result of fluid accumulation i
n the: traumatized region partially from the intraventricular space. P
osttherapeutic values after hyperosmolar albumin administration have r
evealed iso-osmolar CSF, increase in specific gravity (p<0.001), and d
ecrease in BBB permeability (p<0.05). These results are in accordance
with withdrawal of oedema fluid into the ventricles which can be inter
preted as a positive therapeutic effect. Late results in hyperosmolar
group have disclosed a hypo-isc-osmolar CSF, persistent increase in sp
ecific gravity, and no regression. These values have shown that hypero
smolar albumin administration does not interfere with CSF circulation.
Early results of hypoosmolar albumin application are discouraging. Th
is preliminary work of a therapeutic trial on VEE may be a basis for f
uture investigations with different dosages and time modalities.